Name | Title | Contact Details |
---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Good360 is a Alexandria, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BGHS is a state-licensed, non-profit behavioral healthcare provider located in Ansonia, CT, serving the citizens of the Lower Naugatuck Valley and surrounding communities. One out of every five Americans suffers from some form of mental illness. Each
Rose Medical Group is a not-for-profit, membership-based, multi-specialty Physician Hospital Organization and IPA affiliated with the HealthONE Rose Medical Center in Denver, Colorado.
Group Health Plan is a West Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.